|
Characteristics
|
Number of patients (% of total)
|
Prescription of inj. AS in complied doses; n (%)
|
Co-prescription of ACT
|
# (%) of prescriptions that complied with WHO recommendation*
|
|---|
|
< 3 doses
|
3 doses
|
> 3 doses
|
n (%)
|
n (%); [95% CI]
|
|---|
|
Sex
|
|
Female
|
582 (48.9)
|
41 (7.0)
|
492 (84.5)
|
49 (8.4)
|
178 (30.6)
|
153 (26.3); [22.9, 30.0]
|
|
Male
|
609 (51.1)
|
43 (7.1)
|
526 (86.4)
|
40 (6.6)
|
196 (32.2)
|
176 (28.9); [25.4, 32.6]
|
|
Age (years)
|
|
Median (IQR)
|
3.9 (2, 9)
| | | | | |
|
5+
|
476 (40.0)
|
33 (6.9)
|
386 (81.9)
|
57 (12.0)
|
119 (25.0)
|
101 (21.2); [17.8, 25.1]
|
|
Under 5
|
712 (59.7)
|
50 (7.0)
|
630 (88.5)
|
32 (4.5)
|
254 (35.7)
|
227 (31.9); [28.6, 35.4]
|
|
Missing
|
3 (0.3)
|
1 (33.3)
|
2 (66.7)
|
0 (0)
|
1 (33.3)
| |
|
Weight (kg)
|
|
Median (IQR)
|
13 (10, 20)
| | | | | |
|
< 10
|
276 (23.2)
|
19 (6.9)
|
246 (89.1)
|
11 (4.0)
|
89 (32.3)
|
85 (30.8); [25.6, 36.5]
|
|
10–19
|
510 (42.8)
|
35 (6.9)
|
450 (88.2)
|
25 (4.9)
|
191 (37.5)
|
163 (32.0); [28.0, 36.1]
|
|
20–29
|
111 (9.3)
|
8 (7.2)
|
96 (86.5)
|
7 (6.3)
|
32 (28.8)
|
29 (26.1); [18.8, 35.1]
|
|
30+
|
200 (16.8)
|
14 (7.0)
|
149 (74.5)
|
37 (18.5)
|
23 (11.5)
|
16 (8.0); [4.9, 12.7]
|
|
Missing
|
94 (7.9)
|
8 (8.5)
|
77 (81.9)
|
9 (9.6)
|
39 (41.5)
| |
|
Country
|
|
Ghana
|
391 (32.8)
|
31 (7.9)
|
355 (90.8)
|
5 (1.3)
|
336 (85.9)
|
301 (77.0); [72.3, 80.9]
|
|
Uganda
|
800 (67.2)
|
53 (6.6)
|
663 (82.9)
|
84 (10.5)
|
38 (4.8)
|
28 (3.5); [2.4, 5.0]
|
|
Total
|
1191 (100)
|
84 (7.1)
|
1018 (85.5)
|
89 (7.5)
|
374 (31.4)
|
329 (27.6); [25.2, 30.2]
|
- * Compliance was defined as prescription of 3 doses of inj. AS within 24 h and treatment with ACT
